Prophylactic cognitive therapy for depression.
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2010
At a glance
- Drugs Fluoxetine (Primary)
- Indications Depression; Major depressive disorder
- Focus Therapeutic Use
- 01 Jul 2010 Enrolment is complete (n=523) and follow-up continues.
- 12 Mar 2009 Actual patient number (523) added as reported by ClinicalTrials.gov.
- 12 Mar 2009 Planned end date (Jun 2011) added as reported by ClinicalTrials.gov.